Asiaticoside Mitigates Alzheimer's Disease Pathology by Attenuating Inflammation and Enhancing Synaptic Function
Sai Liu1,2, Long Chen1,2, Jinran Li1,2
1State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China.
International Journal of Molecular Sciences
|August 12, 2023
Summary
Asiaticoside (AS) shows promise for Alzheimer's disease (AD) treatment by reducing neuroinflammation and improving cognitive function in mice. This natural compound may offer a new therapeutic avenue for neurodegenerative disorders.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Alzheimer's disease (AD) is characterized by amyloid-β (Aβ) plaques and neurofibrillary tangles.
- Current AD treatments focus on symptom management; novel therapeutic strategies targeting neuroinflammation and synaptic repair are needed.
Purpose of the Study:
- To investigate the neuroprotective effects of Asiaticoside (AS) in a mouse model of Alzheimer's disease.
- To elucidate the mechanisms underlying AS's potential therapeutic benefits in AD.
Main Methods:
- Administration of Asiaticoside (40 mg/kg) in vivo to Aβ1-42-induced AD mice.
- Assessment of cognitive function, neuroinflammation markers, microglial activation, and the p38 MAPK pathway.
Main Results:
- Asiaticoside treatment mitigated cognitive dysfunction in AD mice.
- AS attenuated neuroinflammation by inhibiting microglial activation and pro-inflammatory factors.
- AS may ameliorate cognitive impairment by inhibiting the p38 MAPK pathway and promoting synaptic repair.
Conclusions:
- Asiaticoside demonstrates neuroprotective effects in an AD mouse model.
- AS exhibits potential as a therapeutic agent for Alzheimer's disease by reducing neuroinflammation and enhancing synaptic function.
More Related Videos
Related Concept Videos
01:22Alzheimer's Disease: Treatment
215
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
215
01:26Alzheimer's Disease: Overview
521
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
521
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
155
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
155
02:30siRNA - Small Interfering RNAs
16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K
01:23Role of Neurotransmitters in Memory
628
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
628
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
716
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
716